Nabi Biopharmaceuticals and 3rd Point Reach Agreement
13th Nov 2006, 16:15 GMT
Nabi Biopharmaceuticals and 3rd Point announced that they have reached a settlement relating to a potential consent solicitation.
Nabi Biopharmaceuticals and 3rd Point Reach Agreement related news:
- Nabi, 3rd Point agree to board changes — Financial News News from StratCenter.com
- Nabi Bipharmaceuticals Finally Buckles: Activist Shareholders to Join Board — Bio-Technology News from StratCenter.com
- Nabi, Third Point agree to board changes — Latest news from South Florida Business Journal
- Boeing, union workers reach tentative agreement to end strike — US labour news from LabourStart
- AK Steel, Mansfield union reach tentative agreement — Latest Local News Headlines
- Boeing, Machinists reach accord — The Seattle Times
- Boeing, union workers reach tentative pact to end the strike — The Oakridger:News
- Uganda: Egeland Meets LRA — AllAfrica News: United States, Canada and Africa
- Bulls and Tigers in Platt dispute — BBC Sport | Rugby League | Super League | Bradford | World Edition
- AK Steel's Mansfield workers reach deal — Cincinnati Enquirer - Business All
Latest news from Bio-Technology News from StratCenter.com:
- IBT Labs Invests $2 mln to Expand Pharmaceutical Services Division
- Mercury Computer Systems Collaborates with Boston Univ to Deliver Biotech Application on the Cell BE Processor
- Epratuzumab and Rituximab Have Different Modes of Action
- avVaa World Health Care Products Signs New Spokesman
- China Biopharma Delivers 1.5 mln Doses of Flu Vaccine in China
- Osteologix Appoints Jeremy Curnock Cook to its Board
- Favrille Announces Interim Analysis of Secondary Endpoint from Pivotal Phase 3 Clinical Trial of FavId Following Rituxan in Follicular B-Cell Non-Hodgkin's Lymphoma
- Medarex to Receive Milestone Payment from Amgen
- Arqule Early Cancer Study Shows Progress
- Tanox shares soar in wake of Genentech buyout